Karolinska Institutet
Browse

Perks and considerations when targeting functional non-coding regions with CRISPR/Cas9

Download (9.7 MB)
thesis
posted on 2024-09-02, 23:49 authored by Keyi Geng

Since the CRISPR system was discovered as an adaptive immune response in prokaryotic cells, the past decade has witnessed the engineering and deployment of CRISPR/Cas9 as one of the most efficient and powerful molecular tools. By leveraging the nuclease activity of CRISPR/Cas9, researchers are able to probe the biological functions of genetic elements and dissect molecular interactions by disrupting, activating or inactivating genes. In addition to biological research, the CRISPR/Cas9 toolkit has profoundly revolutionized gene therapy and agricultural products. However, there are many challenges regarding its efficiency, specificity and safety. Continuous efforts are being made to advance techniques and characterize the consequences of genome editing. In this thesis, we describe considerations when targeting genomic regions with CRISPR/Cas9 and provide methods to address some concerns related to efficiency and safety.

In Paper I, we introduced a non-hazardous method of transfecting human cells with large-size CRISPR/Cas9 vectors. By co-transfecting small-size vectors (3 kb) to cells, the delivery efficiency of CRISPR/Cas9 vectors (15 kb) and cell viability was significantly increased. The performance of the method has been verified in a number of hard-to-transfect human cell lines with both electroporation- and liposome-based transfection.

In Paper II, we revealed the complexity of CRISPR/Cas9-induced on-target genomic alterations by combining an advanced droplet-based target enrichment method followed by long-read sequencing and de novo assembly-based analysis. This approach enabled us to dissect the on-target sequence content in the order of kilobases, which was very challenging with many other available methods. With this tool, we uncovered the co-occurrence of multiple on-target rearrangements including duplication, inversion, as well as integrations of exogenous DNA and clustered interchromosomal rearrangements in CRISPR/Cas9-modified human cells. Furthermore, our study demonstrated that unintended genomic alterations could lead to the expression of DNA derived from both the target region and exogenous sources, as well as affect cell proliferation.

In Paper III, we reported a large unexpected genomic deletion in the HAP1 cell line, which is the one of most popular models used in CRISPR/Cas9-mediated experiments. This 287 kb deletion located on Chromosome 10 contains four widely-expressed protein-coding genes including the PTEN gene locus. We detected changes in histone acetylation and transcriptomes in HAP1 cells carrying the deletion. The loss of this genomic locus was not induced by Cas9 off-target nuclease activity. However, the generation of CRISPR/Cas9-modified cells significantly enhanced the frequency of the deletion among cell clones. Furthermore, our analysis indicated that this deletion initially found in HAP1 cells resembled a frequent deletion pattern driven by the PTEN gene in cancer patients.

In conclusion, we have presented two methods: one to improve delivery efficiency and another to detect on-target sequence content with higher resolution. Furthermore, we have revealed unintended genomic aberrations at targeted and non-targeted sites. These observations should be taken into consideration when modifying the genome with CRISPR/Cas9, and a comprehensive genomic validation is necessary.

List of scientific papers

I. Jonas Nørskov Søndergaard, Keyi Geng*, Christian Sommerauer*, Ionut Atanasoai, Xiushan Yin, Claudia Kutter. Successful delivery of large-size CRISPR/Cas9 vectors in hard-to-transfect human cells using small plasmids. Communications Biology. 2020 Jun 19;3(1):319. *Authors contributed equally to this study.
https://doi.org/10.1038/s42003-020-1045-7

II. Keyi Geng, Lara G. Merino, Linda Wedemann, Aniek Martens, Małgorzata Sobota, Yerma P. Sanchez, Jonas Nørskov Søndergaard, Robert J. White, Claudia Kutter. Target-enriched nanopore sequencing and de novo assembly reveals co- occurrences of complex on-target genomic rearrangements induced by CRISPR-Cas9 in human cells. Genome Research. 2022 Oct 1;32(10):1876-91.
https://doi.org/10.1101/gr.276901.122

III. Keyi Geng, Lara G. Merino, Raül G. Veiga, Christian Sommerauer, Janine Epperlein, Eva K. Brinkman, Claudia Kutter. CRISPR-Cas9-mediated genome engineering exaggerates genomic deletion at 10q23.31 including the PTEN gene locus mimicking cancer profiles. Pre-print, bioRxiv April 2023.
https://doi.org/10.1101/2023.04.05.535680

History

Defence date

2023-06-09

Department

  • Department of Microbiology, Tumor and Cell Biology

Publisher/Institution

Karolinska Institutet

Main supervisor

Kutter, Claudia

Co-supervisors

Williams, Cecilia; Baranello, Laura; Ewels, Philip

Publication year

2023

Thesis type

  • Doctoral thesis

ISBN

978-91-8017-024-6

Number of supporting papers

3

Language

  • eng

Original publication date

2023-05-12

Author name in thesis

Geng, Keyi

Original department name

Department of Microbiology, Tumor and Cell Biology

Place of publication

Stockholm

Usage metrics

    Theses

    Categories

    No categories selected

    Keywords

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC